US Patent Issued to LIB Therapeutics on Sept. 9 for "Compositions comprising PCSK9-binding molecules and methods of use" (Ohio Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,236, issued on Sept. 9, was assigned to LIB Therapeutics Inc. (Cincinnati).

"Compositions comprising PCSK9-binding molecules and methods of use" was invented by Tracy S. Mitchell (Cincinnati) and Richard Mealey (Cincinnati).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides pharmaceutical compositions comprising fibronectin based scaffold domain proteins that bind, for example, proprotein convertase subtilisin kexin-9 (PCSK9)."

The patent was filed on May 16, 2023, under Application No. 18/318,343.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect...